Logo

Alzheimer's disease

Payor Coverage a Looming Challenge for Alzheimer's Blood Tests
Premium

The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.

Revvity Gets CE Mark for PCR Test Used to Guide Alzheimer's Therapy

Revvity's Euroimmun subsidiary has launched the EuroRealTime APOE assay in Europe for the detection and differentiation of common forms of the APOE gene.

C2N Diagnostics Receives $15M From GHR Foundation for Development of Tau Tests for Alzheimer's

The tests will measure blood-based tau markers, offering a possible alternative to PET imaging for aiding in diagnosis and staging of Alzheimer's disease.

Memory Treatment Centers to Study Brain Volume Changes in Alzheimer's Patients on Anti-Amyloid Drugs

The Florida-based provider will work with AI software company AiraMed to analyze and measure patients' brain volume from MRIs.

Fujirebio Files Blood-Based Alzheimer's Test With FDA

The test measures levels of p-tau 217 and β-Amyloid 1-42 in human plasma to identify patients with the amyloid brain pathology characteristic of Alzheimer's disease.

Sep 17, 2024

Janssen Pharma to Make CHF 24.6M Milestone Payment to AC Immune Tied to Anti-Tau Alzheimer's Trial

Sep 13, 2024

NKGen Biotech Doses First Patient in Phase II Portion of Alzheimer's Cell Therapy Trial

Sep 5, 2024

Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel

Aug 22, 2024

NICE Doesn't Recommend Biogen, Eisai's Alzheimer's Drug in Draft Guidance Despite MHRA Nod

Aug 9, 2024

Sangamo, Genentech Ink Deal to Advance Genomic Medicines for Alzheimer's, Other Neurological Diseases

Aug 7, 2024

Single Plasma Biomarker Outperforms Others in Comparison of Alzheimer's Tests
Premium

Aug 2, 2024

Hospitals Figuring Out How to Incorporate Beta-Amyloid Testing in Standard Clinical Practice
Premium

Aug 1, 2024

Sunbird Bio's Blood Test Detects Tau Tangles in the Brain in Small Study
Premium

Jul 31, 2024

Eisai Unveils Data Behind Leqembi Monthly Maintenance Dosing Strategy at AAIC
Premium

Jul 30, 2024

Blood Tests Predict Beta-Amyloid Plaque in WashU SEABIRD Study
Premium

Jul 29, 2024

Long-Term Anti-Amyloid Treatment May Delay Alzheimer's Symptom Onset, Study Suggests
Premium

Jul 29, 2024

New Blood Test Shows 90 Percent Accuracy in Diagnosing Alzheimer’s Disease

Jul 26, 2024

EMA's CHMP Recommends Against Approval for Eisai, Biogen's Alzheimer's Drug Leqembi in Europe

Jul 26, 2024

In Brief This Week: Invitae, BioAtla, GeneCentric, AC Immune, ObvioHealth, Allarity, Anixa

Jul 24, 2024

Eisai Touts Leqembi Maintenance Dosing as Docs Weigh Challenge of Getting the Drug to Patients
Premium

Jul 17, 2024

Roche, Beckman Coulter Deals Put Alzpath at Center of Plasma P-tau 217 Alzheimer's Testing Space
Premium

Jul 15, 2024

Beckman Coulter Licensing Alzpath's P-tau 217 Antibody for Use in Alzheimer's Blood Tests

Jul 2, 2024

FDA Approves Eli Lilly's Anti-Amyloid Alzheimer's Drug Kisunla

Jun 28, 2024

Sanofi Invests $40M in Vigil Neuroscience, Gets Exclusive License Option to TREM2 Program

Jun 27, 2024

New Alzheimer's Association Guidelines Emphasize Biological Criteria for Diagnosing, Staging Disease